Skip to main content
. 2023 Sep 13;12(18):5939. doi: 10.3390/jcm12185939

Table 3.

Post-COVID-19 conditions.

At the Time of Survey
PCC
N = 622 (48.0%)
Symptoms at onset (n (%))
    Respiratory a 389 (62.9)
    Gastrointestinal b 353 (57.5)
    Musculoskeletal c 319 (52.0)
    Neurologic d 512 (83.5)
    Constitutional e 494 (80.9)
    ORL f 451 (73.7)
    Other assessed g 189 (31.2)
Symptoms at time of survey (n (%))
    Respiratory a 176 (28.6)
    Gastrointestinal b 161 (26.2)
    Musculoskeletal c 270 (43.9)
    Neurologic d 366 (59.3)
    Constitutional e 176 (28.6)
    ORL f 195 (31.9)
    Other assessed g 128 (21.1)
Fatigue at the time of survey
    FSS (n (%) of ≥5) 181 (31.9)
    SOFA (n (%) of ≥2) 205 (37.8)
    FSS ≥ 5 and SOFA ≥ 2 (n (%)) 131 (23.0)
Psychological distress at the time of survey (n (%) of ≥14) 36 (6.1)

Abbreviations used: N/n = number, FSS = Fatigue Severity Scale, SOFA = Schedule of Fatigue and Anergia/General Practice. a Includes cough, sibilance, hissing, stridor. b Includes nausea/vomiting, dysphagia, diarrhea, abdominal pain. c Includes joint pain and lower limb edema. d Includes aphasia, dysarthria, confusion, convulsions, ageusia, dysgeusia, anosmia, paresthesia of the lower or upper limbs. e Includes fever, dizziness, inappetence. f Includes earache, sore throat, hemoptysis, nasal discharge or congestion. g Includes eye infection, chest pain, rash.